and leukemia: clinical value of their detection by immunocytochemistry Proteins encoded by genes involved in chromosomal alterations in lymphoma

http://bloodjournal.hematologylibrary.org/content/99/2/409.full.html Updated information and services can be found at: (434 articles) Review Articles • (4217 articles) Neoplasia • (231 articles) Cell Cycle • Articles on similar topics can be found in the following Blood collections http://bloodjournal.hematologylibrary.org/site/misc/rights.xhtml#repub_requests Information about reproducing this article in parts or in its entirety may be found online at: http://bloodjournal.hematologylibrary.org/site/misc/rights.xhtml#reprints Information about ordering reprints may be found online at: http://bloodjournal.hematologylibrary.org/site/subscriptions/index.xhtml Information about subscriptions and ASH membership may be found online at:

[1]  刘金明,et al.  IL-13受体α2降低血吸虫病肉芽肿的炎症反应并延长宿主存活时间[英]/Mentink-Kane MM,Cheever AW，Thompson RW，et al//Proc Natl Acad Sci U S A , 2005 .

[2]  B. Falini.  Anaplastic large cell lymphoma: pathological, molecular and clinical features , 2001 .

[3]  L. Meltesen,et al.  Unusual childhood extramedullary hematologic malignancy with natural killer cell properties that contains tropomyosin 4--anaplastic lymphoma kinase gene fusion. , 2001, Blood.

[4]  M. Shimizu,et al.  Anaplastic Lymphoma Kinase Expression in Inflammatory Pseudotumors , 2001, The American journal of surgical pathology.

[5]  P. Marynen,et al.  The NPM-ALK and the ATIC-ALK fusion genes can be detected in non-neoplastic cells. , 2001, The American journal of pathology.

[6]  H. Kosaka,et al.  l-Arginine improves endothelial function in renal artery of hypertensive Dahl rats , 2001, Journal of hypertension.

[7]  S. Pileri,et al.  CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. , 2000, Blood.

[8]  E. Vichinsky,et al.  Patterns of Arginine and Nitric Oxide in Patients With Sickle Cell Disease With Vaso-occlusive Crisis and Acute Chest Syndrome , 2000, Journal of pediatric hematology/oncology.

[9]  J. Esteve,et al.  Rapid diagnosis of acute promyelocytic leukemia by analyzing the immunocytochemical pattern of the PML protein with the monoclonal antibody PG-M3. , 2000, American journal of clinical pathology.

[10]  B. Falini,et al.  Immune response to the ALK oncogenic tyrosine kinase in patients with anaplastic large-cell lymphoma. , 2000, Blood.

[11]  F. Birg,et al.  Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Groupe Français de Cytogénétique Hématologique, Groupe de Français d'Hematologie Cellulaire, UK Cancer Cytogenetics Group and BIOMED 1 European Community-Concerted Action "Mole , 2000, Blood.

[12]  M. Ladanyi.  Aberrant ALK tyrosine kinase signaling. Different cellular lineages, common oncogenic mechanisms. , 2000, The American journal of pathology.

[13]  P. D. Dal Cin,et al.  TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. , 2000, The American journal of pathology.

[14]  R. Nagel,et al.  Impaired nitric oxide-mediated vasodilation in transgenic sickle mouse. , 2000, American journal of physiology. Heart and circulatory physiology.

[15]  E. Kang,et al.  Normal circulating adult human red blood cells contain inactive NOS proteins. , 2000, The Journal of laboratory and clinical medicine.

[16]  K. Pulford,et al.  Expression of the ALK tyrosine kinase gene in neuroblastoma. , 2000, The American journal of pathology.

[17]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[18]  E. Campo,et al.  Lymphomas expressing ALK fusion protein(s) other than NPM-ALK. , 1999, Blood.

[19]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[20]  C. Brugnara,et al.  Endothelins activate Ca2+-gated K+ channels via endothelin B receptors in CD-1 mouse erythrocytes. , 1999, American journal of physiology. Cell physiology.

[21]  B. Falini,et al.  Genetic diagnosis and molecular monitoring in the management of acute promyelocytic leukemia. , 1999, Blood.

[22]  U. Alon,et al.  Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[23]  P. Marynen,et al.  The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. , 1999, Blood.

[24]  T. Greiner,et al.  Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. , 1999, Blood.

[25]  S. Pileri,et al.  ALK+ lymphoma: clinico-pathological findings and outcome. , 1999, Blood.

[26]  G. Delsol,et al.  Leukaemic presentation of small cell variant anaplastic large cell lymphoma: report of four cases , 1999, British journal of haematology.

[27]  J. Licht,et al.  Deregulation of NPM and PLZF in a variant t(5;17) case of acute promyelocytic leukemia , 1999, Oncogene.

[28]  B Falini,et al.  Detection of normal and chimeric nucleophosmin in human cells. , 1999, Blood.

[29]  R. Nagel,et al.  Two distinct pathways mediate the formation of intermediate density cells and hyperdense cells from normal density sickle red blood cells. , 1998, Blood.

[30]  L. Trümper,et al.  Detection of the t(2;5)‐associated NPM/ALK fusion cDNA in peripheral blood cells of healthy individuals , 1998, British journal of haematology.

[31]  R. Nagel,et al.  Peroxynitrite formation and apoptosis in transgenic sickle cell mouse kidneys. , 1998, Kidney international.

[32]  S. Pileri,et al.  ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum. , 1998, The American journal of pathology.

[33]  J. Chan,et al.  Anaplastic Large Cell Lymphoma: Redefining Its Morphologic Spectrum and Importance of Recognition of the ALK‐Positive Subset , 1998, Advances in anatomic pathology.

[34]  J. Mehta,et al.  Evidence for the presence of L-arginine-nitric oxide pathway in human red blood cells: relevance in the effects of red blood cells on platelet function. , 1998, Journal of cardiovascular pharmacology.

[35]  S. Higano,et al.  Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans. , 1998, Circulation.

[36]  H. Fathallah,et al.  Deoxygenation of sickle red blood cells stimulates KCl cotransport without affecting Na+/H+ exchange. , 1998, The American journal of physiology.

[37]  P. Pelicci,et al.  The acute promyelocytic leukaemia specific PML and PLZF proteins localize to adjacent and functionally distinct nuclear bodies , 1998, Oncogene.

[38]  S. Pileri,et al.  ALK-positive lymphoma: a single disease with a broad spectrum of morphology. , 1998, Blood.

[39]  K. Pulford,et al.  Nucleolar localization of the nucleophosmin-anaplastic lymphoma kinase is not required for malignant transformation. , 1998, Cancer research.

[40]  T. Sternsdorf,et al.  Evidence for Covalent Modification of the Nuclear Dot–associated Proteins PML and Sp100 by PIC1/SUMO-1 , 1997, The Journal of cell biology.

[41]  P. Freemont,et al.  Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia. , 1997, Blood.

[42]  M. Seto,et al.  Anaplastic large cell lymphoma: a distinct molecular pathologic entity: a reappraisal with special reference to p80(NPM/ALK) expression. , 1997, The American journal of surgical pathology.

[43]  G. Morgan,et al.  The rapid diagnosis of acute promyelocytic leukaemia using PML (5E10) monoclonal antibody , 1997, British journal of haematology.

[44]  S. Pileri,et al.  Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML). , 1997, Blood.

[45]  H. Herbst,et al.  Absence of anaplastic lymphoma kinase (ALK) and Epstein–Barr virus gene products in primary cutaneous anaplastic large cell lymphoma and lymphomatoid papulosis , 1997, The British journal of dermatology.

[46]  R. Nagel,et al.  Red Blood Cells of a Transgenic Mouse Expressing High Levels of Human Hemoglobin S Exhibit Deoxy-stimulated Cation Flux , 1997, The Journal of Membrane Biology.

[47]  J M Davies,et al.  Leukemia-associated retinoic acid receptor alpha fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[48]  R. Wells,et al.  Fusion of retinoic acid receptor α to NuMA, the nuclear mitotic apparatus protein, by a variant translocation in acute promyelocytic leukaemia , 1997, Nature Genetics.

[49]  S. Lessin,et al.  The pathogenesis of large cell transformation in cutaneous T‐cell lymphoma is not associated with t(2;5)(p23;q35) chromosomal translocation , 1997, Journal of cutaneous pathology.

[50]  J. Guillet,et al.  Peptides derived from the whole sequence of BCR‐ABL bind to several class I molecules allowing specific induction of human cytotoxic T lymphocytes , 1997, European journal of immunology.

[51]  E. Campo,et al.  The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements. , 1997, The American journal of pathology.

[52]  J. Zweier,et al.  Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[53]  A. Hudetz,et al.  Mechanisms of stroke in sickle cell disease: sickle erythrocytes decrease cerebral blood flow in rats after nitric oxide synthase inhibition. , 1997, Blood.

[54]  R. Nagel,et al.  K:CI cotransport in red cells of transgenic mice expressing high levels of human hemoglobin S , 1997, American journal of hematology.

[55]  V. Lew,et al.  Stochastic nature and red cell population distribution of the sickling-induced Ca2+ permeability. , 1997, The Journal of clinical investigation.

[56]  C. Naeve,et al.  ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK) , 1997, Oncogene.

[57]  Wei Tang,et al.  Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. , 1997, Blood.

[58]  M. Cleary,et al.  The HRX proto-oncogene product is widely expressed in human tissues and localizes to nuclear structures. , 1997, Blood.

[59]  F. Behm,et al.  Monoclonal antibodies specific to the acute lymphoblastic leukemia t(1;19)-associated E2A/pbx1 chimeric protein: characterization and diagnostic utility. , 1997, Blood.

[60]  S. Pileri,et al.  Frequent expression of the NPM-ALK chimeric fusion protein in anaplastic large-cell lymphoma, lympho-histiocytic type. , 1997, The American journal of pathology.

[61]  K. Pulford,et al.  Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis , 1997, Molecular and cellular biology.

[62]  P. Brousset,et al.  A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation. , 1997, Blood.

[63]  K. Pulford,et al.  Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. , 1997, Blood.

[64]  E. Jaffe,et al.  Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: evidence for distinct cellular origin. , 1997, Blood.

[65]  C. Melief,et al.  Recognition of BCR-ABL positive leukemic blasts by human CD4+ T cells elicited by primary in vitro immunization with a BCR-ABL breakpoint peptide. , 1996, Blood.

[66]  R. Nagel,et al.  Immunohistochemical localization of hepatic nitric oxide synthase in normal and transgenic sickle cell mice: the effect of hypoxia. , 1996, Blood.

[67]  H. Kantarjian,et al.  Comparison of bcr-abl protein expression and Philadelphia chromosome analyses in chronic myelogenous leukemia patients. , 1996, American journal of clinical pathology.

[68]  G. Pawelec,et al.  BCR/ABL leukemia oncogene fusion peptides selectively bind to certain HLA-DR alleles and can be recognized by T cells found at low frequency in the repertoire of normal donors. , 1996, Blood.

[69]  C. Peschle,et al.  Effects on differentiation by the promyelocytic leukemia PML/RARalpha protein depend on the fusion of the PML protein dimerization and RARalpha DNA binding domains. , 1996, The EMBO journal.

[70]  S. Mori,et al.  The clinicopathological features of anaplastic large cell lymphomas expressing p80NPM/ALK. , 1996, Leukemia & lymphoma.

[71]  R. Rousset,et al.  Exclusion of Int-6 from PML Nuclear Bodies by Binding to the HTLV-I Tax Oncoprotein , 1996, Science.

[72]  S. Snyder,et al.  Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[73]  T. Rector,et al.  Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure. , 1996, Circulation.

[74]  R. Nagel,et al.  Renal nitric oxide synthases in transgenic sickle cell mice. , 1996, Kidney international.

[75]  A. Sette,et al.  Specific human cellular immunity to bcr-abl oncogene-derived peptides. , 1996, Blood.

[76]  H. Satoh,et al.  Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5). , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[77]  M. Kadin,et al.  The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin. , 1996, Blood.

[78]  S. Corey,et al.  The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion. , 1996, Blood.

[79]  S. Pittaluga,et al.  Molecular characterization of the t(2;5) (p23; q35) translocation in anaplastic large cell lymphoma (Ki-1) and Hodgkin's disease. , 1996, Blood.

[80]  S. Raimondi,et al.  The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1. , 1996, Oncogene.

[81]  N. Sacchi,et al.  Detection and subcellular localization of an AML1 chimeric protein in the t(8;21) positive acute myeloid leukemia. , 1996, Oncogene.

[82]  J. Licht,et al.  Reduced and altered DNA-binding and transcriptional properties of the PLZF-retinoic acid receptor-alpha chimera generated in t(11;17)-associated acute promyelocytic leukemia. , 1996, Oncogene.

[83]  R. Krumlauf,et al.  Leukemia translocation gene, PLZF, is expressed with a speckled nuclear pattern in early hematopoietic progenitors. , 1995, Blood.

[84]  W. Chan,et al.  Transcripts of the npm-alk fusion gene in anaplastic large cell lymphoma, Hodgkin's disease, and reactive lymphoid lesions. , 1995, Blood.

[85]  E. Schuuring,et al.  Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma. , 1995, Blood.

[86]  E. Jaffe,et al.  Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease. , 1995, Blood.

[87]  S. Mori,et al.  Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity. , 1995, Leukemia.

[88]  H. Ginsburg,et al.  Erythrocyte stages of Plasmodium falciparum exhibit a high nitric oxide synthase (NOS) activity and release an NOS-inducing soluble factor , 1995, The Journal of experimental medicine.

[89]  H. Stein,et al.  ALK gene products in anaplastic large cell lymphomas and Hodgkin's disease. , 1995, Blood.

[90]  M. V. van Dijk,et al.  Specific immunologic recognition of the tumor-specific E2A-PBX1 fusion-point antigen in t(1;19)-positive pre-B cells. , 1995, Leukemia.

[91]  R. Evans,et al.  Rapid diagnosis of acute promyelocytic leukemia by immunohistochemical localization of PML/RAR-alpha protein , 1995 .

[92]  J. Downing,et al.  Molecular detection of the (2;5) translocation of non-Hodgkin's lymphoma by reverse transcriptase-polymerase chain reaction. , 1995, Blood.

[93]  N. Harris,et al.  Cyclin D1 expression in non-Hodgkin's lymphomas. Detection by immunohistochemistry. , 1995, American journal of clinical pathology.

[94]  S. J. Holt,et al.  Ligand-induced translocation of epidermal growth factor receptor to the nucleus of NR6/HER fibroblasts is serum dependent. , 1995, Experimental cell research.

[95]  J. Licht,et al.  Expression of the zinc-finger gene PLZF at rhombomere boundaries in the vertebrate hindbrain. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[96]  H. Frierson,et al.  Low frequency association of the t(2;5)(p23;q35) chromosomal translocation with CD30+ lymphomas from American and Asian patients. A reverse transcriptase-polymerase chain reaction study. , 1995, The American journal of pathology.

[97]  H. Satoh,et al.  Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry. , 1994, Blood.

[98]  D. Catovsky,et al.  Differential expression of c-myc protein in B and T lymphocytes. , 1994, Leukemia.

[99]  N. Zegers,et al.  Recognition of the ALL-specific BCR-ABL junction in P190bcr-abl by monoclonal antibody ER-FP1. , 1994, Leukemia.

[100]  A. Deisseroth,et al.  BCR-ABL protein expression in peripheral blood cells of chronic myelogenous leukemia patients undergoing therapy. , 1994, Blood.

[101]  H. Satoh,et al.  Hyperphosphorylation of a novel 80 kDa protein-tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line, AMS3. , 1994, Oncogene.

[102]  S. Alper,et al.  Treatment with oral clotrimazole blocks Ca(2+)-activated K+ transport and reverses erythrocyte dehydration in transgenic SAD mice. A model for therapy of sickle cell disease. , 1994, The Journal of clinical investigation.

[103]  D N Shapiro,et al.  Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. , 1994, Science.

[104]  S. J. Holt,et al.  Epidermal growth factor induced tyrosine phosphorylation of nuclear proteins associated with translocation of epidermal growth factor receptor into the nucleus. , 1994, Biochemical pharmacology.

[105]  R. Kurzrock,et al.  Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation. , 1993, The Journal of clinical investigation.

[106]  J. Whitlock,et al.  A Small‐Cell‐Predominant Variant of Primary Ki‐1 (CD30)+ T‐Cell Lymphoma , 1993, The American journal of surgical pathology.

[107]  A. Zelent,et al.  Fusion between a novel Krüppel‐like zinc finger gene and the retinoic acid receptor‐alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia. , 1993, The EMBO journal.

[108]  S. Dhut,et al.  Normal c-abl gene protein--a nuclear component. , 1991, Oncogene.

[109]  G. Stamatoyannopoulos,et al.  Rapid increase in red blood cell density driven by K:Cl cotransport in a subset of sickle cell anemia reticulocytes and discocytes. , 1991, Blood.

[110]  E. Rubin,et al.  Hypoxia-induced in vivo sickling of transgenic mouse red cells. , 1991, The Journal of clinical investigation.

[111]  C. Enwonwu,et al.  Nitrogen metabolism in sickle cell anemia: free amino acids in plasma and urine. , 1990, The American journal of the medical sciences.

[112]  C. Fletcher,et al.  Sarcomatoid variant of anaplastic large-cell Ki-1 lymphoma. , 1990, The American journal of surgical pathology.

[113]  S. Pileri,et al.  Lymphohistiocytic T‐cell lymphoma (anaplastic large cell lymphoma CD30+/Ki‐1 + with a high content of reactive histiocytes) , 1990, Histopathology.

[114]  R. Warnke,et al.  CD30‐positive large cell lymphomas (‘Ki‐1 lymphoma’) are associated with a chromosomal translocation involving 5q35 , 1990, British journal of haematology.

[115]  R. Larson,et al.  The t(2;5)(p23;q35): a recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphoma. , 1989, Leukemia.

[116]  D. Baltimore,et al.  The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization , 1989, Cell.

[117]  M. Sasaki,et al.  A novel translocation, t(2;5)(p23;q35), in childhood phagocytic large T-cell lymphoma mimicking malignant histiocytosis. , 1989, Blood.

[118]  G. Grosveld,et al.  Antibody recognition of the tumor-specific bcr-abl joining region in chronic myeloid leukemia , 1989, The Journal of experimental medicine.

[119]  S. Mitani,et al.  Expression of c‐myc Oncogens Product and ras Family Oncogene Products in Various Human Malignant Lymphomas Defined by Immunohistochemical Techniques , 1988, Cancer.

[120]  M. Horton,et al.  Identification of two normal bcr gene products in the cytoplasm. , 1988, Oncogene.

[121]  R. Nagel,et al.  Dense cells in sickle cell anemia: the effects of gene interaction. , 1984, Blood.

[122]  R. Ochs,et al.  Localization of nucleolar phosphoproteins B23 and C23 during mitosis. , 1983, Experimental cell research.

[123]  A. Zelenetz,et al.  Clinical and Molecular Characterization of a Rare Syndrome of Acute Promyelocytic Leukemia Associated With Translocation , 2002 .

[124]  T. Manabe,et al.  Bone marrow involvement in NPM-ALK-positive lymphoma: report of two cases. , 1999, Pathology, research and practice.

[125]  M. Kadin,et al.  The pathologic and clinical spectrum of anaplastic large cell lymphoma and correlation with ALK gene dysregulation. , 1999, American journal of clinical pathology.

[126]  A. Dejean,et al.  Conjugation with the ubiquitin‐related modifier SUMO‐1 regulates the partitioning of PML within the nucleus , 1998, The EMBO journal.

[127]  A. Dejean,et al.  Trivalent antimonials induce degradation of the PML-RAR oncoprotein and reorganization of the promyelocytic leukemia nuclear bodies in acute promyelocytic leukemia NB4 cells. , 1998, Blood.

[128]  M. Kadin.  Anaplastic large cell lymphoma and its morphological variants. , 1997, Cancer surveys.

[129]  K. Papadopoulos,et al.  Naturally processed tissue- and differentiation stage-specific autologous peptides bound by HLA class I and II molecules of chronic myeloid leukemia blasts. , 1997, Blood.

[130]  M. Ladanyi.  The NPM/ALK gene fusion in the pathogenesis of anaplastic large cell lymphoma. , 1997, Cancer surveys.

[131]  J. Shuster,et al.  Use of an anti-ALK antibody in the characterization of anaplastic large-cell lymphoma of childhood. , 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

[132]  A. Bernheim,et al.  High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining. , 1996, Blood.

[133]  B. Zehnbauer,et al.  BCR-ABL gene rearrangement and expression of primitive hematopoietic progenitors in chronic myeloid leukemia. , 1993, Blood.

[134]  M. Groudine,et al.  Control of c-myc regulation in normal and neoplastic cells. , 1991, Advances in cancer research.

[135]  L. Skow,et al.  A mouse model for beta-thalassemia. , 1983, Cell.

[136]  R. Nagel,et al.  High expression of human 8s- and a-globins in transgenic mice: Erythrocyte abnormalities, organ damage, and the effect of hypoxia , 2022 .